Actions of dehydroepiandrosterone and its sulfate in the central nervous system: Effects on cognition and emotion in animals and humans

Brain Research Reviews

Volumn 30, Issue 3, 1999, Pages 264-288

  Wolf, Oliver T ^a,b   Kirschbaum, Clemens ^c  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ROCKEFELLER UNIVERSITY   (United States)

^c UNIVERSITY OF TRIER   (Germany)

Author keywords

Cognition; Emotion; Hormone

Indexed keywords

ANDROGEN; ESTROGEN; GLUCOCORTICOID ANTAGONIST; INSULIN; NEUROTRANSMITTER RECEPTOR; PRASTERONE; PRASTERONE SULFATE; RECEPTOR; SOMATOMEDIN C; STEROID RECEPTOR;

AGED; BIOSYNTHESIS; CENTRAL NERVOUS SYSTEM; COGNITION; EMOTION; HORMONE BLOOD LEVEL; HORMONE RELEASE; HUMAN; MEMORY; MOOD; NERVE CELL DIFFERENTIATION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; REVIEW;

EID: 0032737985     PISSN: 01650173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-0173(99)00021-1     Document Type: Article

References (308)

1. Abadie J.M., Wright B., Correa G., Browne E.S., Porter J.R., Svec F. Effect of dehydroepiandrosterone on neurotransmitter levels and appetite regulation of the obese Zucker rat. The Obesity Research Program. Diabetes. 42:1993;662-669.
2. Adams J., Garcia M., Rochefort H. Estrogenic effects of physiological concentrations of 5-androstene-3 beta, 17 beta-diol and its metabolism in MCF7 human breast cancer cells. Cancer Res. 41:1981;4720-4726.
3. Adams J.B. Control of secretion and the function of C19-delta 5-steroids of the human adrenal gland. Mol. Cell. Endocrinol. 41:1985;1-17.
4. Aldred S., Waring R.H. Localisation of dehydroepiandrosterone sulphotransferase in adult rat brain. Brain Res. Bull. 48:1999;291-296.
5. Allen C.N., Crawford I.L. GABAergic agents in the medial septal nucleus affect hippocampal theta rhythm and acetylcholine utilization. Brain Res. 322:1984;261-267.
6. Anderson D.C. The adrenal androgen-stimulating hormone does not exist. Lancet. 2:1980;454-456.
7. Barden N., Reul J.M., Holsboer F. Do antidepressants stabilize mood through actions on the hypothalamic-pituitary-adrenocortical system? Trends Neurosci. 18:1995;6-11.
8. Barrett-Connor E., Edelstein S.L. A prospective study of dehydroepiandrosterone sulfate and cognitive function in an older population: the Rancho Bernardo study. J. Am. Geriatr. Soc. 42:1994;420-423.
9. Baulieu E.E. Neurosteroids: of the nervous system, by the nervous system, for the nervous system. Recent Prog. Horm. Res. 52:1997;1-32.
10. E.E. Baulieu, Steroid hormones in the brain: several mechanisms?, in: K. Fuxe, L.F. Agnati (Eds.), Receptor Interactions, Macmillan, Basingstoke, UK, 1981, pp. 89-104.
11. Baulieu E.E., Robel P. Dehydroepiandrosterone (DHEA) and dehydroepiandrosterone sulfate (DHEAS) as neuroactive neurosteroids. Proc. Natl. Acad. Sci. USA. 95:1998;4089-4091.
12. Baulieu E.E., Robel P. Non-genomic mechanisms of action of steroid hormones. Ciba Found. Symp. 191:1995;24-37.
13. Belisle S., Schiff I., Tulchinsky D. The use of constant infusion of unlabeled dehydroepiandrosterone for the assessment of its metabolic clearance rate, its half-life, and its conversion into estrogens. J. Clin. Endocrinol. Metab. 50:1980;117-121.
14. Bergeron R., de Montigny C., Debonnel G. Potentiation of neuronal NMDA response induced by dehydroepiandrosterone and its suppression by progesterone: effects mediated via sigma receptors. J. Neurosci. 16:1996;1193-1202.
15. Berkman L.F., Seeman T.E., Albert M., Blazer D., Kahn R., Mohs R., Finch C., Schneider E., Cotman C., McClearn G.et al. High, usual and impaired functioning in community-dwelling older men and women: findings from the MacArthur Foundation Research Network on Successful Aging. J. Clin. Epidemiol. 46:1993;1129-1140.
16. Berr C., Lafont S., Debuire B., Dartigues J.F., Baulieu E.E. Relationships of dehydroepiandrosterone sulfate in the elderly with functional, psychological, and mental status, and short-term mortality: a French community-based study. Proc. Natl. Acad. Sci. USA. 93:1996;13410-13415.
17. Bird C.E., Masters V., Clark A.F. Dehydroepiandrosterone sulfate: kinetics of metabolism in normal young men and women. Clin. Invest. Med. 7:1984;119-122.
18. Birge S.J. Is there a role for estrogen replacement therapy in the prevention and treatment of dementia? J. Am. Geriatr. Soc. 44:1996;865-870.
19. Bloch M., Schmidt P.J., Danaceau M.A., Adams L.F., Rubinow D.R. Dehydroepiandrosterone treatment of midlife dysthymia. Biol. Psychiatry. 45:1999;1533-1541.
20. Bodnoff S.R., Humphreys A.G., Lehman J.C., Diamond D.M., Rose G.M., Meaney M.J. Enduring effects of chronic corticosterone treatment on spatial learning, synaptic plasticity, and hippocampal neuropathology in young and mid-aged rats. J. Neurosci. 15:1995;61-69.
21. Bolhuis J.J., Reid I.C. Effects of intraventricular infusion of the N-methyl-D-aspartate (NMDA) receptor antagonist AP5 on spatial memory of rats in a radial arm maze. Behav. Brain. Res. 47:1992;151-157.
22. Bologa L., Sharma J., Roberts E. Dehydroepiandrosterone and its sulfated derivative reduce neuronal death and enhance astrocytic differentiation in brain cell cultures. J. Neurosci. Res. 17:1987;225-234.
23. Bowlby M.R. Pregnenolone sulfate potentiation of N-methyl-D-aspartate receptor channels in hippocampal neurons. Mol. Pharmacol. 43:1993;813-819.
24. Bradbury M.J., Akana S.F., Cascio C.S., Levin N., Jacobson L., Dallman M.F. Regulation of basal ACTH secretion by corticosterone is mediated by both type I (MR) and type II (GR) receptors in rat brain. J. Steroid Biochem. Mol. Biol. 40:1991;133-142.
25. Brigell D.F., Fang V.S., Rosenfield R.L. Recovery of responses to ovine corticotropin-releasing hormone after withdrawal of a short course of glucocorticoid. J. Clin. Endocrinol. Metab. 74:1992;1036-1039.
26. Bruder J.M., Sobek L., Oettel M. Dehydroepiandrosterone stimulates the estrogen response element. J. Steroid Biochem. Mol. Biol. 62:1997;461-466.
27. Buzsaki G., Horvath Z., Urioste R., Hetke J., Wise K. High-frequency network oscillation in the hippocampus. Science. 256:1992;1025-1027.
28. Carette B., Poulain P. Excitatory effect of dehydroepiandrosterone, its sulphate ester and pregnenolone sulphate, applied by iontophoresis and pressure, on single neurones in the septo-preoptic area of the guinea pig. Neurosci. Lett. 45:1984;205-210.
29. Cascio C., Prasad V.V., Lin Y.Y., Lieberman S., Papadopoulos V. Detection of P450c17-independent pathways for dehydroepiandrosterone (DHEA) biosynthesis in brain glial tumor cells. Proc. Natl. Acad. Sci. USA. 95:1998;2862-2867.
30. Casson P.R., Santoro N., Elkind-Hirsch K., Carson S.A., Hornsby P.J., Abraham G., Buster J.E. Postmenopausal dehydroepiandrosterone administration increases free insulin-like growth factor-I and decreases high-density lipoprotein: a six-month trial. Fertil. Steril. 70:1998;107-110.
31. Castellano C., McGaugh J.L. Effects of post-training bicuculline and muscimol on retention: lack of state dependency. Behav. Neural Biol. 54:1990;156-164.
32. Cherrier M., Asthana S., Plymate S., Baker L., Matsumoto A., Bremner W., Lofgren C., Cubberty L., Petrova A., LaTendresse S., Scroggin K., Craft S. Effects of testosterone on cognition in healthy elderly men. Soc. Neurosci. 24:1998;24118. Abstracts.
33. Church A.C., Flexner J.B., Flexner L.B. Complementary memory storage sites in mice: their development as affected by the competitive NMDA receptor antagonist, CPP. Pharmacol. Biochem. Behav. 52:1995;237-240.
34. Cohen P., Ocrant I., Fielder P.J., Neely E.K., Gargosky S.E., Deal C.I., Ceda G.P., Youngman O., Pham H., Lamson G.et al. Insulin-like growth factors (IGFs): implications for aging. Psychoneuroendocrinology. 17:1992;335-342.
35. Compagnone N.A., Bulfone A., Rubenstein J.L., Mellon S.H. Expression of the steroidogenic enzyme P450scc in the central and peripheral nervous systems during rodent embryogenesis. Endocrinology. 136:1995;2689-2696.
36. Compagnone N.A., Mellon S.H. Dehydroepiandrosterone: a potential signalling molecule for neocortical organization during development. Proc. Natl. Acad. Sci. USA. 95:1998;4678-4683. see comments.
37. Conrad C.D., Galea L.A., Kuroda Y., McEwen B.S. Chronic stress impairs rat spatial memory on the Y maze, and this effect is blocked by tianeptine pretreatment. Behav. Neurosci. 110:1996;1321-1334.
38. Cordero M.I., Merino J.J., Sandi C. Correlational relationship between shock intensity and corticosterone secretion on the establishment and subsequent expression of contextual fear conditioning. Behav. Neurosci. 112:1998;885-891.
39. Corpas E., Harman S.M., Blackman M.R. Human growth hormone and human aging. Endocr. Rev. 14:1993;20-39.
40. Corpechot C., Robel P., Axelson M., Sjovall J., Baulieu E.E. Characterization and measurement of dehydroepiandrosterone sulfate in rat brain. Proc. Natl. Acad. Sci. USA. 78:1981;4704-4707.
41. Costa E., Guidotti A., Mao C.C., Suria A. New concepts on the mechanism of action of benzodiazepines. Life Sci. 17:1975;167-185.
42. Craft S., Dagogo-Jack S.E., Wiethop B.V., Murphy C., Nevins R.T., Fleischman S., Rice V., Newcomer J.W., Cryer P.E. Effects of hyperglycemia on memory and hormone levels in dementia of the Alzheimer type: a longitudinal study. Behav. Neurosci. 107:1993;926-940.
43. Craft S., Zallen G., Baker L.D. Glucose and memory in mild senile dementia of the Alzheimer type. J. Clin. Exp. Neuropsych. 14:1992;253-267.
44. Cunningham S.K., McKenna T.J. Dissociation of adrenal androgen and cortisol secretion in Cushing's syndrome. Clin. Endocrinol. (Oxford). 41:1994;795-800.
45. Cutler G.B. Jr., Glenn M., Bush M., Hodgen G.D., Graham C.E., Loriaux D.L. Adrenarche: a survey of rodents, domestic animals, and primates. Endocrinology. 103:1978;2112-2118.
46. de Kloet E.R., Oitzl M.S., Joels M. Functional implications of brain corticosteroid receptor diversity. Cell. Mol. Neurobiol. 13:1993;433-455.
47. De Kloet E.R., Vreugdenhil E., Oitzl M.S., Joels M. Brain corticosteroid receptor balance in health and disease. Endocr. Rev. 19:1998;269-301.
48. de Peretti E., Forest M.G. Pattern of plasma dehydroepiandrosterone sulfate levels in humans from birth to adulthood: evidence for testicular production. J. Clin. Endocrinol. Metab. 47:1978;572-577.
49. de Quervain D.J., Roozendaal B., McGaugh J.L. Stress and glucocorticoids impair retrieval of long-term spatial memory. Nature. 394:1998;787-790.
50. Debonnel G. Current hypotheses on sigma receptors and their physiological role: possible implications in psychiatry. J. Psychiatr. Neurosci. 18:1993;157-172.
51. Debonnel G., Bergeron R., de Montigny C. Potentiation by dehydroepiandrosterone of the neuronal response to N-methyl-D-aspartate in the CA3 region of the rat dorsal hippocampus: an effect mediated via sigma receptors. J. Endocrinol. 150:1996;S33-S42.
52. Debonnel G., de Montigny C. Modulation of NMDA and dopaminergic neurotransmissions by sigma ligands: possible implications for the treatment of psychiatric disorders. Life Sciences. 58:1996;721-734.
53. Del Cerro S., Garcia Estrada J., Garcia Segura L.M. Neuroactive steroids regulate astroglia morphology in hippocampal cultures from adult rats. Glia. 14:1995;65-71.
54. Diamond D.M., Bennett M.C., Fleshner M., Rose G.M. Inverted-U relationship between the level of peripheral corticosterone and the magnitude of hippocampal primed burst potentiation. Hippocampus. 2:1992;421-430.
55. Diamond D.M., Branch B.J., Fleschner M. The neurosteroid dehydroepiandrosterone sulfate (DHEAS) enhances hippocampal primed burst, but not long-term, potentiation. Neurosci. Lett. 202:1996;204-208.
56. Diamond D.M., Branch B.J., Fleshner M., Rose G.M. Effects of dehydroepiandrosterone sulfate and stress on hippocampal electrophysiological plasticity. Ann. N.Y. Acad. Sci. 774:1995;304-307.
57. D.M. Diamond, M. Fleshner, Constraints on the DHEAS induced enhancement of hippocampal function: nonlinear dose-response functions and DHEAS-stress interactions, in: M. Kalimi, W. Regelson (Eds.), Dehydroepiandrosterone (DHEA): Biochemical, Physiological and Clinical Aspects, Volume II, Walter de Gruyer, Berlin, in press.
58. D.M. Diamond, M. Fleshner, N. Ingersoll, G.M. Rose, The DHEAS-induced enhancement of hippocampal primed burst potentiation is blocked by psychological stress, Stress, in press.
59. Diamond D.M., Fleshner M., Ingersoll N., Rose G.M. Psychological stress impairs spatial working memory: relevance to electrophysiological studies of hippocampal function. Behav. Neurosci. 110:1996;661-672.
60. Diamond M.P., Grainger D.A., Laudano A.J., Starick Zych K., DeFronzo R.A. Effect of acute physiological elevations of insulin on circulating androgen levels in nonobese women. J. Clin. Endocrinol. Metab. 72:1991;883-887.
61. Diamond P., Cusan L., Gomez J.L., Belanger A., Labrie F. Metabolic effects of 12-month percutaneous dehydroepiandrosterone replacement therapy in postmenopausal women. J. Endocrinol. 150:1996;S43-S50.
62. Dodt C., Theine K.J., Uthgenannt D., Born J., Fehm H.L. Basal secretory activity of the hypothalamo-pituitary-adrenocortical axis is enhanced in healthy elderly. An assessment during undisturbed night-time sleep. Eur. J. Endocrinol. 131:1994;443-450.
63. Dubrovsky B. Natural steroids counteracting some actions of putative depressogenic steroids on the central nervous system: potential therapeutic benefits. Med. Hypotheses. 49:1997;51-55.
64. Endoh A., Kristiansen S.B., Casson P.R., Buster J.E., Hornsby P.J. The zona reticularis is the site of biosynthesis of dehydroepiandrosterone and dehydroepiandrosterone sulfate in the adult human adrenal cortex resulting from its low expression of 3 beta-hydroxysteroid dehydrogenase. J. Clin. Endocrinol. Metab. 81:1996;3558-3565.
65. Engelhardt W., Friess K., Hartung E., Sold M., Dierks T. EEG and auditory evoked potential P300 compared with psychometric tests in assessing vigilance after benzodiazepine sedation and antagonism. Br. J. Anaesth. 69:1992;75-80.
66. Ferreira M.B., Da Silva R.C., Medina J.H., Izquierdo I. Late posttraining memory processing by entorhinal cortex: involvement of NMDA and GABAergic receptors. Pharmacol. Biochem. Behav. 41:1992;767-771.
67. 2+ channel current in freshly isolated hippocampal CA1 neurons. Eur. J. Pharmacol. 202:1991;269-272.
68. Fillit H., Weinreb H., Cholst I., Luine V., McEwen B., Amador R., Zabriskie J. Observations in a preliminary open trial of estradiol therapy for senile dementia - Alzheimer's type. Psychoneuroendocrinology. 11:1986;337-345.
69. Fleshner M., Pugh C.R., Tremblay D., Rudy J.W. DHEA-S selectively impairs contextual-fear conditioning: support for the antiglucocorticoid hypothesis. Behav. Neurosci. 111:1997;512-517.
70. Flood J.F., Morley J.E., Roberts E. Memory-enhancing effects in male mice of pregnenolone and steroids metabolically derived from it. Proc. Natl. Acad. Sci. USA. 89:1992;1567-1571.
71. Flood J.F., Roberts E. Dehydroepiandrosterone sulfate improves memory in aging mice. Brain Res. 448:1988;178-181.
72. Flood J.F., Smith G.E., Roberts E. Dehydroepiandrosterone and its sulfate enhance memory retention in mice. Brain Res. 447:1988;269-278.
73. Flood J.F., Vidal D., Bennett E.L., Orme A.E., Vasquez S., Jarvik M.E. Memory facilitating and anti-amnesic effects of corticosteroids. Pharmacol. Biochem. Behav. 8:1978;81-87.
74. Flynn M.A., Weaver-Osterholtz D., Sharpe-Timms K.L., Allen S., Krause G. Dehydroepiandrosterone replacement in aging humans. J. Clin. Endocrinol. Metab. 84:1999;1527-1533.
75. Folstein M.F., Folstein S.E., McHugh P.R. 'Mini-Mental State'. A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 12:1975;189-198.
76. M. Forest, Steroidhormone, in: H.R.D. (Ed.), Endokrinologie, Urban und Schwarzenberg, München, Germany, 1989, pp. 74-95.
77. Friess E., Trachsel L., Guldner J., Schier T., Steiger A., Holsboer F. DHEA administration increases rapid eye movement sleep and EEG power in the sigma frequency range. Am. J. Physiol. 268:1995;E107-E113.
78. Frye C.A., Sturgis J.D. Neurosteroids affect spatial/reference, working, and long-term memory of female rats. Neurobiol. Learn. Mem. 64:1995;83-96.
79. Gold P.E. Role of glucose in regulating the brain and cognition. Am. J. Clin. Nutr. 61:1995;987S-995S.
80. Goodyer I.M., Herbert J., Altham P.M. Adrenal steroid secretion and major depression in 8- to 16-year-olds: III. Influence of cortisol/DHEA ratio at presentation on subsequent rates of disappointing life events and persistent major depression. Psychol. Med. 28:1998;265-273.
81. Goodyer I.M., Herbert J., Altham P.M., Pearson J., Secher S.M., Shiers H.M. Adrenal secretion during major depression in 8- to 16-year-olds: I. Altered diurnal rhythms in salivary cortisol and dehydroepiandrosterone (DHEA) at presentation. Psychol. Med. 26:1996;245-256.
82. Gray A., Feldman H.A., McKinlay J.B., Longcope C. Age, disease, and changing sex hormone levels in middle-aged men: results of the Massachusetts Male Aging Study. J. Clin. Endocrinol. Metab. 73:1991;1016-1025.
83. Griffing G.T. Dinosaurs and steroids. J. Clin. Endocrinol. Metab. 77:1993;1450-1451. Editorial.
84. Guazzo E.P., Kirkpatrick P.J., Goodyer I.M., Shiers H.M., Herbert J. Cortisol, dehydroepiandrosterone (DHEA), and DHEA sulfate in the cerebrospinal fluid of man: relation to blood levels and the effects of age. J. Clin. Endocrinol. Metab. 81:1996;3951-3960.
85. Han D.H., Hansen P.A., Chen M.M., Holloszy J.O. DHEA treatment reduces fat accumulation and protects against insulin resistance in male rats. J. Gerontol. 53:1998;B19-B24.
86. Haning R.V. Jr., Chabot M., Flood C.A., Hackett R., Longcope C. Metabolic clearance rate (MCR) of dehydroepiandrosterone sulfate (DS), its metabolism to dehydroepiandrosterone, androstenedione, testosterone, and dihydrotestosterone, and the effect of increased plasma DS concentration on DS MCR in normal women. J. Clin. Endocrinol. Metab. 69:1989;1047-1052.
87. Hansen C.R. Jr., Kroll J., Mackenzie T.B. Dehydroepiandrosterone and affective disorders. Am. J. Psychiatry. 139:1982;386-387.
88. Haskell S.G., Richardson E.D., Horwitz R.I. The effect of estrogen replacement therapy on cognitive function in women: a critical review of the literature. J. Clin. Epidemiol. 50:1997;1249-1264.
89. Haug M., Ouss Schlegel M.L., Spetz J.F., Brain P.F.et al. Suppressive effects of dehydroepiandrosterone and 3-b-methylandrost-5-en-17-one on attack towards lactating female intruders by castrated male mice. Physiol. Behav. 46:1989;955-959.
90. Hechter O., Grossman A., Chatterton R.T. Jr. Relationship of dehydroepiandrosterone and cortisol in disease. Med. Hypotheses. 49:1997;85-91.
91. Henderson V.W., Paganini-Hill A., Emanuel C.K., Dunn M.E., Buckwalter J.G. Estrogen replacement therapy in older women. Comparisons between Alzheimer's disease cases and nondemented control subjects. Arch. Neurol. 51:1994;896-900.
92. Heuser I., Deuschle M., Luppa P., Schweiger U., Standhardt H., Weber B. Increased diurnal plasma concentrations of dehydroepiandrosterone in depressed patients. J. Clin. Endocrinol. Metab. 83:1998;3130-3133.
93. Hobe G., Hillesheim H.G., Schon R., Reddersen G., Knappe R., Bannasch P., Mayer D. Sex differences in dehydroepiandrosterone metabolism in the rat: different plasma levels following ingestion of DHEA-supplemented diet and different metabolite patterns in plasma, bile and urine. Horm. Metab. Res. 26:1994;326-329.
94. Holsboer F., Barden N. Antidepressants and hypothalamic-pituitary-adrenocortical regulation. Endocr. Rev. 17:1996;187-205.
95. Holsboer F., Trachsler E., Stohler R., Hatzinger M. Repeated administration of the combined dexamethasone-human corticotropin releasing hormone stimulation test during treatment of depression. Psychiatry Res. 38:1991;163-171.
96. Hornsby P.J. Biosynthesis of DHEAS by the human adrenal cortex and its age-related decline. Ann. N.Y. Acad. Sci. 774:1995;29-46.
97. Hung T.T., LeMaire J. The effects of corticotropin, opioid peptides and crude pituitary extract on the production of dehydroepiandrosterone and corticosterone by mature rat adrenal cells in tissue culture. J. Steroid Biochem. 29:1988;721-726.
98. Imamura M., Prasad C. Modulation of GABA-gated chloride ion influx in the brain by dehydroepiandrosterone and its metabolites. Biochem. Biophys. Res. Commun. 243:1998;771-775.
99. Introini-Collison I.B., Castellano C., McGaugh J.L. Interaction of GABAergic and beta-noradrenergic drugs in the regulation of memory storage. Behav. Neural Biol. 61:1994;150-155.
100. 2+ responses: structure-activity studies. J. Pharmacol. Exp. Ther. 271:1994;677-682.
101. Izquierdo I. Pharmacological evidence for a role of long-term potentiation in memory. FASEB J. 8:1994;1139-1145.
102. Jacobson L., Sapolsky R. The role of the hippocampus in feedback regulation of the hypothalamic-pituitary-adrenocortical axis. Endocr. Rev. 12:1991;118-134.
103. Janowsky J.S., Oviatt S.K., Orwoll E.S. Testosterone influences spatial cognition in older men. Behav. Neurosci. 108:1994;325-332.
104. Joels M. Steroid hormones and excitability in the mammalian brain. Front. Neuroendocrinol. 18:1997;2-48.
105. 3H ]DHEA binding in rat liver Biochem. Biophys. Res. Commun. 156:1988;22-29.
106. Kalimi M., Shafagoj Y., Loria R., Padgett D., Regelson W. Anti-glucocorticoid effects of dehydroepiandrosterone (DHEA). Mol. Cell. Biochem. 131:1994;99-104.
107. Kalmijn S., Launer L.J., Stolk R.P., de Jong F.H., Pols H.A., Hofman A., Breteler M.M., Lamberts S.W. A prospective study on cortisol, dehydroepiandrosterone sulfate, and cognitive function in the elderly. J. Clin. Endocrinol. Metab. 83:1998;3487-3492.
108. Kamei H., Kameyama T., Nabeshima T. (+)-SKF-10,047 and dextromethorphan ameliorate conditioned fear stress through the activation of phenytoin-regulated sigma 1 sites. Eur. J. Pharmacol. 299:1996;21-28.
109. Kathol R.G., Jaeckle R.S., Lopez J.F., Meller W.H. Pathophysiology of HPA axis abnormalities in patients with major depression: an update. Am. J. Psychiatry. 146:1989;311-317.
110. Katz S., Downs T.D., Cash H.R., Grotz R.C. Progress in development of the index of ADL. Gerontologist. 10:1970;20-30.
111. Keller Wood M.E., Dallman M.F. Corticosteroid inhibition of ACTH secretion. Endocr. Rev. 5:1984;1-24.
112. Kern W., Dodt C., Born J., Fehm H.L. Changes in cortisol and growth hormone secretion during nocturnal sleep in the course of aging. J. Gerontol., Ser. A. 51:1996;M3-M9.
113. Kimonides V.G., Khatibi N.H., Svendsen C.N., Sofroniew M.V., Herbert J. Dehydroepiandrosterone (DHEA) and DHEA-sulfate (DHEAS) protect hippocampal neurons against excitatory amino acid-induced neurotoxicity. Proc. Natl. Acad. Sci. USA. 95:1998;1852-1857.
114. Kirschbaum C., Pirke K.M., Hellhammer D.H. The 'Trier Social Stress Test' - a tool for investigating psychobiological stress responses in a laboratory setting. Neuropsychobiology. 28:1993;76-81.
115. Kirschbaum C., Wolf O.T., May M., Wippich W., Hellhammer D.H. Stress- and treatment-induced elevations of cortisol levels associated with impaired declarative memory in healthy adults. Life Sciences. 58:1996;1475-1483.
116. Kishimoto Y., Hoshi M. Dehydroepiandrosterone sulphate in rat brain: incorporation from blood and metabolism in vivo. J. Neurochem. 19:1972;2207-2215.
117. Korol D.L., Gold P.E. Glucose, memory, and aging. Am. J. Clin. Nutr. 67:1998;764S-771S.
118. Kovacs G.L., Telegdy G., Lissak K. Dose-dependent action of corticosteroids on brain serotonin content and passive avoidance behavior. Horm. Behav. 8:1977;155-165.
119. Kreitmann B., Bayard F. Androgen interaction with the oestrogen receptor in human tissues. J. Steroid Biochem. 11:1979;1589-1595.
120. Krnjevic K., Ropert N., Casullo J. Septohippocampal disinhibition. Brain Res. 438:1988;182-192.
121. Kudielka B.M., Hellhammer J., Hellhammer D.H., Wolf O.T., Pirke K.M., Varadi E., Pilz J., Kirschbaum C. Sex differences in endocrine and psychological responses to psychosocial stress in healthy elderly subjects and the impact of a 2-week dehydroepiandrosterone treatment. J. Clin. Endocrinol. Metab. 83:1998;1756-1761.
122. Kulikowski J.J., McGlone F.F., Kranda K., Ott H. Are the amplitudes of visual evoked potentials sensitive indices of hangover effects after repeated doses of benzodiazepines? Psychopharmacol., Suppl. 1:1984;154-164.
123. Labrie F. Intracrinology. Mol. Cell. Endocrinol. 78:1991;C113-8.
124. Labrie F., Belanger A., Simard J., Van L.-T., Labrie C. DHEA and peripheral androgen and estrogen formation: intracinology. Ann. N.Y. Acad. Sci. 774:1995;16-28.
125. Labrie F., Belanger A., Van L.T., Labrie C., Simard J., Cusan L., Gomez J.L., Candas B. DHEA and the intracrine formation of androgens and estrogens in peripheral target tissues: its role during aging. Steroids. 63:1998;322-328.
126. Lacroix C., Fiet J., Benais J.P., Gueux B., Bonete R., Villette J.M., Gourmel B., Dreux C. Simultaneous radioimmunoassay of progesterone, androst-4-enedione, pregnenolone, dehydroepiandrosterone and 17-hydroxyprogesterone in specific regions of human brain. J. Steroid Biochem. 28:1987;317-325.
127. Lakshmi S., Balasubramanian A.S. The distribution of estrone sulphatase, dehydroepiandrosterone sulphatase, and arylsulphatase C in the primate (Macaca radiata) brain and pituitary. J. Neurochem. 37:1981;358-362.
128. Landfield P.W., Baskin R.K., Pitler T.A. Brain aging correlates: retardation by hormonal-pharmacological treatments. Science. 214:1981;581-584.
129. Lane M.A., Ingram D.K., Ball S.S., Roth G.S. Dehydroepiandrosterone sulfate: a biomarker of primate aging slowed by calorie restriction. J. Clin. Endocrinol. Metab. 82:1997;2093-2096.
130. Lavallee B., Provost P.R., Kahwash Z., Nestler J.E., Belanger A. Effect of insulin on serum levels of dehydroepiandrosterone metabolites in men. Clin. Endocrinol. 46:1997;93-100.
131. Leblhuber F., Neubauer C., Peichl M., Reisecker F., Steinparz F.X., Windhager E., Dienstl E. Age and sex differences of dehydroepiandrosterone sulfate (DHEAS) and cortisol (CRT) plasma levels in normal controls and Alzheimer's disease (AD). Psychopharmacology. 111:1993;23-26.
132. Leblhuber F., Windhager E., Neubauer C., Weber J., Reisecker F., Dienstl E. Antiglucocorticoid effects of DHEA-S in Alzheimer's disease. Am. J. Psychiatry. 149:1992;1125-1126.
133. Leblhuber F., Windhager E., Reisecker F., Steinparz F.X., Dienstl E. Dehydroepiandrosterone sulphate in Alzheimer disease. Lancet. ii:1990;449.
134. Leeb-Lundberg F., Olsen R.W. Interactions of barbiturates of various pharmacological categories with benzodiazepine receptors. Mol. Pharmacol. 21:1982;320-328.
135. Legrain S., Berr C., Frenoy N., Gourlet V., Debuire B., Baulieu E.E. Dehydroepiandrosterone sulfate in a long-term care aged population. Gerontology. 41:1995;343-351.
136. Leverenz J.B., Wilkinson C.W., Wamble M., Corbin S., Grabber J.E., Raskind M.A., Peskind E.R. Effect of chronic high-dose exogenous cortisol on hippocampal neuronal number in aged nonhuman primates. J. Neurosci. 19:1999;2356-2361.
137. Li P.K., Rhodes M.E., Burke A.M., Johnson D.A. Memory enhancement mediated by the steroid sulfatase inhibitor (p-O-sulfamoyl)-N-tetradecanoyl tyramine. Life Sci. 60:1997;PL45-PL51.
138. Li P.K., Rhodes M.E., Jagannathan S., Johnson D.A. Reversal of scopolamine induced amnesia in rats by the steroid sulfatase inhibitor estrone-3-O-sulfamate. Cognit. Brain Res. 2:1995;251-254.
139. Liang K.C., Hon W., Davis M. Pre- and posttraining infusion of N-methyl-D-aspartate receptor antagonists into the amygdala impair memory in an inhibitory avoidance task. Behav. Neurosci. 108:1994;241-253.
140. Liu C.H., Laughlin G.A., Fischer U.G., Yen S.S. Marked attenuation of ultradian and circadian rhythms of dehydroepiandrosterone in postmenopausal women: evidence for a reduced 17,20-desmolase enzymatic activity. J. Clin. Endocrinol. Metab. 71:1990;900-906.
141. Longcope C. Dehydroepiandrosterone metabolism. J. Endocrinol. 150:1996;S125-S127.
142. Lupien S., de Leon M., de Santi S., Convit A., Tarshish C., Nair N.V.P., McEwen B.S., Hauger R.L., Meaney M.J. Cortisol levels during human aging predict hippocampal atrophy and memory deficits. Nat. Neurosci. 1:1998;69-73.
143. Lupien S., Lecours A.R., Lussier I., Schwartz G., Nair N.P., Meaney M.J. Basal cortisol levels and cognitive deficits in human aging. J. Neurosci. 14:1994;2893-2903.
144. Lupien S., Lecours A.R., Schwartz G., Sharma S., Hauger R.L., Meaney M.J., Nair N.P. Longitudinal study of basal cortisol levels in healthy elderly subjects: evidence for subgroups. Neurobiol. Aging. 17:1996;95-105.
145. Lupien S.J., Gaudreau S., Tchiteya B.M., Maheu F., Sharma S., Nair N.P.V., Hauger R.L., McEwen B.S., Meaney M.J. Stress-induced declarative memory impairment in healthy elderly subjects: relationship to cortisol reactivity. J. Clin. Endocrinol. Metab. 82:1997;2070-2075.
146. Lupien S.J., McEwen B.S. The acute effects of corticosteroids on cognition: integration of animal and human model studies. Brain Res. Rev. 24:1997;1-27.
147. Magarinos A.M., McEwen B.S. Stress-induced atrophy of apical dendrites of hippocampal CA3c neurons: involvement of glucocorticoid secretion and excitatory amino acid receptors. Neuroscience. 69:1995;89-98.
148. Magarinos A.M., McEwen B.S., Flugge G., Fuchs E. Chronic psychosocial stress causes apical dendritic atrophy of hippocampal CA3 pyramidal neurons in subordinate tree shrews. J. Neurosci. 16:1996;3534-3540.
149. Majewska M.D. Neurosteroids: endogenous bimodal modulators of the GABA-A receptor. Mechanism of action and physiological significance. Prog. Neurobiol. 38:1992;379-395.
150. Malhotra A.K., Pinals D.A., Weingartner H., Sirocco K., Missar C.D., Pickar D., Breier A. NMDA receptor function and human cognition: the effects of ketamine in healthy volunteers. Neuropsychopharmacology. 14:1996;301-307.
151. Martignoni E., Costa A., Sinforiani E., Liuzzi A., Chiodine P., Mauri M., Bono G., Nappi G. The brain as a target for adrenocortical steroids: cognitive implications. Psychoneuroendocrinology. 17:1992;343-354. Special Issue: Psychoneuroendocrinology of aging: the brain as a target organ of hormones.
152. Martin F., Siddle D.A., Gourley M., Taylor J.et al. P300 and traffic scenes: the effect of temazepam. Biol. Psychol. 33:1992;225-240.
153. Matsuno K., Senda T., Kobayashi T., Mita S. Involvement of sigma 1 receptor in (+)-N-allylnormetazocine-stimulated hippocampal cholinergic functions in rats. Brain Res. 690:1995;200-206.
154. Matsuno K., Senda T., Matsunaga K., Mita S. Ameliorating effects of sigma receptor ligands on the impairment of passive avoidance tasks in mice: involvement in the central acetylcholinergic system. Eur. J. Pharmacol. 261:1994;43-51.
155. Maurice T., Junien J.L., Privat A. Dehydroepiandrosterone sulfate attenuates dizocilpine-induced learning impairment in mice via sigma 1-receptors. Behav. Brain Res. 83:1997;159-164.
156. Maurice T., Lockhart B.P. Neuroprotective and anti-amnesic potentials of sigma (sigma) receptor ligands. Prog. Neuro-Psychopharmacol. Biol. Psychiatry. 21:1997;69-102.
157. 3H ]SKF-10,047 binding to sigma 1 receptors in the mouse forebrain J. Neurosci. Res. 46:1996;734-743.
158. Maurice T., Roman F.J., Su T.P., Privat A. Beneficial effects of sigma agonists on the age-related learning impairment in the senescence-accelerated mouse (SAM). Brain Res. 733:1996;219-230.
159. Maurice T., Su T.P., Privat A. Sigma1 (sigma 1) receptor agonists and neurosteroids attenuate B25-35-amyloid peptide-induced amnesia in mice through a common mechanism. Neuroscience. 83:1998;413-428.
160. McEwen B.S. Possible mechanisms for atrophy of the human hippocampus. Mol. Psychiatry. 2:1997;255-262.
161. McEwen B.S., Alves S.E. Estrogen action in the central nervous system. Endocr. Rev. 20:1999;279-307.
162. McEwen B.S., Alves S.E., Bulloch K., Weiland N.G. Ovarian steroids and the brain: implications for cognition and aging. Neurology. 48:1997;S8-S15.
163. McEwen B.S., Gould E., Orchinik M., Weiland N.G., Woolley C.S. Oestrogens and the structural and functional plasticity of neurons: implications for memory, ageing and neurodegenerative processes. Ciba Found. Symp. 191:1995;52-66.
164. McEwen B.S., Sapolsky R.M. Stress and cognitive function. Curr. Opin. Neurobiol. 5:1995;205-216.
165. Meaney M.J., Mitchell J.B., Aitken D.H., Bhatnagar S., Bodnoff S., Invy L.I., Sarrieau A. The effects of neonatal handling on the development of the adrenocortical response to stress: implications for neuropathology and cognitive deficits in later life. Psychoneuroendocrinology. 16:1991;85-103.
166. Meikle A.W., Douhuck R.W., Araneo B.A., Stringham J.D., Evans T.G., Spruance S.L., Daynes R.A. The presence of a dehydroepiandrosterone-specific receptor binding complex in murine T cells. J. Steroid. Biochem. Mol. Biol. 42:1992;293-304.
167. Melchior C.L., Ritzmann R.F. Dehydroepiandrosterone is an anxiolytic in mice on the plus maze. Pharmacol. Biochem. Behav. 47:1994;437-441.
168. Melchior C.L., Ritzmann R.F. Neurosteroids block the memory-impairing effects of ethanol in mice. Pharmacol. Biochem. Beh. 53:1996;51-56.
169. Meldrum D.R., Davidson B.J., Tataryn I.V., Judd H.L. Changes in circulating steroids with aging in postmenopausal women. Obstet. Gynecol. 57:1981;624-628.
170. Mellon S.H., Shively J.E., Miller W.L. Human proopiomelanocortin-(79-96), a proposed androgen stimulatory hormone, does not affect steroidogenesis in cultured human fetal adrenal cells. J. Clin. Endocrinol. Metab. 72:1991;19-22.
171. Meyer J.H., Gruol D.L. Dehydroepiandrosterone sulfate alters synaptic potentials in area CA1 of the hippocampal slice. Brain Res. 633:1994;253-261.
172. 3H ]norepinephrine release evoked by N-methyl-D-aspartate in the rat hippocampus Proc. Natl. Acad. Sci. USA. 92:1995;3774-3778.
173. Morales A.J., Haubricht R.H., Hwang J.Y., Asakura H., Yen S.S.C. The
174. Morales A.J., Nolan J.J., Nelson J.C., Yen S.S.C. Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age. J. Clin. Endocrinol. Metab. 78:1994;1360-1367.
175. Morrison M.F., Katz I.R., Parmelee P., Boyce A.A., TenHave T. Dehydroepiandrosterone sulfate (DHEA-S) and psychiatric and laboratory measures of frailty in a residential care population. Am. J. Ger. Psych. 6:1998;277-284.
176. Mortaud S., Donsez-Darcel E., Roubertoux P.L., Degrelle H. Murine steroid sulfatase gene expression in the brain during postnatal development and adulthood. Neurosci. Let. 215:1996;145-148.
177. Murphy B.E. Steroids and depression. J. Steroid Biochem. Mol. Biol. 38:1991;537-559.
178. Nasman B., Olsson T., Backstrom T., Eriksson S., Grankvist K., Viitanen M., Bucht G. Serum dehydroepiandrosterone sulfate in Alzheimer's disease and in multi-infarct dementia. Biol. Psychiatry. 30:1991;684-690.
179. Nasman B., Olsson T., Seckl J.R., Eriksson S., Viitanen M., Bucht G., Carlstrom K. Abnormalities in adrenal androgens, but not of glucocorticoids, in early Alzheimer's disease. Psychoneuroendocrinology. 20:1995;83-94.
180. Nemeroff C.B. The corticotropin-releasing factor (CRF) hypothesis of depression: new findings and new directions. Mol. Psychiatry. 1:1996;336-342.
181. Nemeroff C.B., Widerlov E., Bissette G., Walleus H., Karlsson I., Eklund K., Kilts C.D., Loosen P.T., Vale W. Elevated concentrations of CSF corticotropin-releasing factor-like immunoreactivity in depressed patients. Science. 226:1984;1342-1344.
182. Nestler J.E. Advances in understanding the regulation and biologic actions of dehydroepiandrosterone. Curr. Opin. Endocrinol. Diabetes. 3:1996;202-211.
183. Nestler J.E., Beer N.A., Jakubowicz D.J., Beer R.M. Effects of a reduction in circulating insulin by metformin on serum dehydroepiandrosterone sulfate in nondiabetic men. J. Clin. Endocrinol. Metab. 78:1994;549-554.
184. Nestler J.E., Beer N.A., Jakubowicz D.J., Colombo C., Beer R.M. Effects of insulin reduction with benfluorex on serum dehydroepiandrosterone (DHEA), DHEA sulfate, and blood pressure in hypertensive middle-aged and elderly men. J. Clin. Endocrinol. Metab. 80:1995;700-706.
185. Nestler J.E., Kahwash Z. Sex-specific action of insulin to acutely increase the metabolic clearance rate of dehydroepiandrosterone in humans. J. Clin. Invest. 94:1994;1484-1489.
186. Newcomer J.W., Craft S., Hershey T., Askins K., Bardgett M.E. Glucocorticoid-induced impairment in declarative memory performance in adult humans. J. Neurosci. 14:1994;2047-2053.
187. Nieschlag E., Loriaux D.L., Ruder H.J., Zucker I.R., Kirschner M.A., Lipsett M.B. The secretion of dehydroepiandrosterone and dehydroepiandrosterone sulphate in man. J. Endocrinol. 57:1973;123-134.
188. Ohkura T., Isse K., Akazawa K., Hamamoto M., Yaoi Y., Hagino N. Evaluation of estrogen treatment in female patients with dementia of the Alzheimer type. Endocr. J. 41:1994;361-371.
189. Ohkura T., Isse K., Akazawa K., Hamamoto M., Yaoi Y., Hagino N. Long-term estrogen replacement therapy in female patients with dementia of the Alzheimer type: 7 case reports. Dementia. 6:1995;99-107.
190. Ohl F., Fuchs E. Differential effects of chronic stress on memory processes in the tree shrew. Cognit. Brain Res. 7:1999;379-387.
191. Ohl F., Fuchs E. Memory performance in tree shrews: effects of stressful experiences. Neurosci. Biobehav. Rev. 23:1998;319-323.
192. Oitzl M.S., de Kloet E.R. Selective corticosteroid antagonists modulate specific aspects of spatial orientation learning. Behav. Neurosci. 106:1992;62-71.
193. Oitzl M.S., Fluttert M., de Kloet E.R. Acute blockade of hippocampal glucocorticoid receptors facilitates spatial learning in rats. Brain Res. 797:1998;159-162.
194. Okabe T., Haji M., Takayanagi R., Adachi M., Imasaki K., Kurimoto F., Watanabe T., Nawata H. Up-regulation of high-affinity dehydroepiandrosterone binding activity by dehydroepiandrosterone in activated human T lymphocytes. J. Clin. Endocrinol. Metab. 80:1995;2993-2996.
195. Olsen R.W., McCabe R.T., Wamsley J.K. GABAA receptor subtypes: autoradiographic comparison of GABA, benzodiazepine, and convulsant binding sites in the rat central nervous system. J. Chem. Neuroanat. 3:1990;59-76.
196. Orentreich N., Brind J.L., Rizer R.L., Vogelman J.H. Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood. J. Clin. Endocrinol. Metab. 59:1984;551-555.
197. Osran H., Reist C., Chen C.C., Lifrak E.T., Chicz DeMet A., Parker L.N. Adrenal androgens and cortisol in major depression. Am. J. Psychiatry. 150:1993;806-809.
198. Paganini-Hill A., Henderson V.W. Estrogen deficiency and risk of Alzheimer's disease in women. Am. J. Epidemiol. 140:1994;256-261.
199. Paganini-Hill A., Henderson V.W. Estrogen replacement therapy and risk of Alzheimer disease. Arch. Intern. Med. 156:1996;2213-2217.
200. Parada-Turska J., Turski W.A. Excitatory amino acid antagonists and memory: effect of drugs acting at N-methyl-D-aspartate receptors in learning and memory tasks. Neuropharmacology. 29:1990;1111-1116.
201. Park I.H., Han B.K., Jo D.H. Distribution and characterization of neurosteroid sulfatase from the bovine brain. J. Steroid Biochem. Mol. Biol. 62:1997;315-320.
202. Parker C.R. Jr., Baxter C.R. Divergence in adrenal steroid secretory pattern after thermal injury in adult patients. J. Trauma. 25:1985;508-510.
203. Parker C.R.J., Mixon R.L., Brissie R.M., Grizzle W.E. Aging alters zonation in the adrenal cortex of men. J. Clin. Endocrinol. Metab. 82:1997;3898-3901.
204. Parker L., Gral T., Perrigo V., Skowksy R. Decreased adrenal androgen sensitivity to ACTH during aging. Metabolism. 30:1981;601-604.
205. L.N. Parker, Adrenal Androgens in Clinical Medicine, Academic Press, San Diego, CA, 1989.
206. Parker L.N. Control of adrenal androgen secretion. Endocrinol. Metab. Clin. North Am. 20:1991;401-421.
207. Parker L.N., Levin E.R., Lifrak E.T. Evidence for adrenocortical adaptation to severe illness. J. Clin. Endocrinol. Metab. 60:1985;947-952.
208. Parker L.N., Lifrak E.T., Odell W.D. A 60,000 molecular weight human pituitary glycopeptide stimulates adrenal androgen secretion. Endocrinology. 113:1983;2092-2096.
209. Parker L.N., Odell W.D. Control of adrenal androgen secretion. Endocr. Rev. 1:1980;392-410.
210. Pavlides C., Watanabe Y., Magarinos A.M., McEwen B.S. Opposing roles of type I and type II adrenal steroid receptors in hippocampal long-term potentiation. Neuroscience. 68:1995;387-394.
211. Pavlov E.P., Harman S.M., Chrousos G.P., Loriaux D.L., Blackman M.R. Responses of plasma adrenocorticotropin, cortisol, and dehydroepiandrosterone to ovine corticotropin-releasing hormone in healthy aging men. J. Clin. Endocrinol. Metab. 62:1986;767-772.
212. Phillips S.M., Sherwin B.B. Effects of estrogen on memory function in surgically menopausal women. Psychoneuroendocrinology. 17:1992;485-495.
213. Pincus T., Summey J.A., Soraci S.A. Jr., Wallston K.A., Hummon N.P. Assessment of patient satisfaction in activities of daily living using a modified Stanford Health Assessment Questionnaire. Arthritis Rheum. 26:1983;1346-1353.
214. Polich J. Meta-analysis of P300 normative aging studies. Psychophysiology. 33:1996;334-353.
215. Poortman J., Prenen J.A., Schwarz F., Thijssen J.H. Interaction of delta-5-androstene-3beta, 17beta-diol with estradiol and dihydrotestosterone receptors in human myometrial and mammary cancer tissue. J. Clin. Endocrinol. Metab. 40:1975;373-379.
216. Prasad A., Imamura M., Prasad C. Dehydroepiandrosterone decreases behavioral despair in high- but not low-anxiety rats. Physiol. Behav. 62:1997;1053-1057.
217. Pugh C.R., Tremblay D., Fleshner M., Rudy J.W. A selective role for corticosterone in contextual-fear conditioning. Behav. Neurosci. 111:1997;503-511.
218. Quirion R., Bowen W.D., Itzhak Y., Junien J.L., Musacchio J.M., Rothman R.B., Su T.P., Tam S.W., Taylor D.P. A proposal for the classification of sigma binding sites. Trends Pharmacol. Sci. 13:1992;85-86.
219. Rajkowski K.M., Robel P., Baulieu E.E. Hydroxysteroid sulfotransferase activity in the rat brain and liver as a function of age and sex. Steroids. 62:1997;427-436.
220. Ravaglia G., Forti P., Maioli F., Boschi F., Bernardi M., Pratelli L., Pizzoferrato A., Gasbarrini G. The relationship of dehydroepiandrosterone sulfate (DHEAS) to endocrine-metabolic parameters and functional status in the oldest-old. Results from an Italian study on healthy free-living over-ninety-year-olds. J. Clin. Endocrinol. Metab. 81:1996;1173-1178.
221. Reddy D.S., Kaur G., Kulkarni S.K. Sigma (sigma1) receptor mediated antidepressant-like effects of neurosteroids in the Porsolt forced swim test. NeuroReport. 9:1998;3069-3073.
222. Reddy D.S., Kulkarni S.K. Differential anxiolytic effects of neurosteroids in the mirrored chamber behavior test in mice. Brain Res. 752:1997;61-71.
223. Reddy D.S., Kulkarni S.K. The effects of neurosteroids on acquisition and retention of a modified passive-avoidance learning task in mice. Brain Res. 791:1998;108-116.
224. Reddy D.S., Kulkarni S.K. Possible role of nitric oxide in the nootropic and antiamnesic effects of neurosteroids on aging- and dizocilpine-induced learning impairment. Brain Res. 799:1998;215-229.
225. Rhodes M.E., Li P.K., Burke A.M., Johnson D.A. Enhanced plasma DHEAS, brain acetylcholine and memory mediated by steroid sulfatase inhibition. Brain Res. 773:1997;28-32.
226. Rhodes M.E., Li P.K., Flood J.F., Johnson D.A. Enhancement of hippocampal acetylcholine release by the neurosteroid dehydroepiandrosterone: an in vivo microdialysis study. Brain Res. 733:1996;284-286.
227. Rice M.S., Graves A.B., McCurry S.M., Larson E.B. Estrogen replacement therapy and cognitive function in postmenopausal women without dementia. Am. J. Med. 103:1997;26S-35S.
228. Rich B.H., Rosenfield R.L., Lucky A.W., Helke J.C., Otto P. Adrenarche: changing adrenal response to adrenocorticotropin. J. Clin. Endocrinol. Metab. 52:1981;1129-1136.
229. Risch S.C., Nemeroff C.B. Neurochemical alterations of serotonergic neuronal systems in depression. J. Clin. Psychiatry. 53:1992;3-7.
230. Rison R.A., Stanton P.K. Long-term potentiation and N-methyl-D-aspartate receptors: foundations of memory and neurologic disease? Neurosci. Biobehav. Rev. 19:1995;533-552.
231. Robel P., Bourreau E., Corpechot C., Dang D.C., Halberg F., Clarke C., Haug M., Schlegel M.L., Synguelakis M., Vourch C., Baulieu E.E. Neuro-steroids: 3 beta-hydroxy-delta 5-derivatives in rat and monkey brain. J. Steroid Biochem. 27:1987;649-655.
232. Robel P., Young J., Corpechot C., Mayo W., Perche F., Haug M., Simon H., Baulieu E.E. Biosynthesis and assay of neurosteroids in rats and mice: functional correlates. J. Steroid Biochem. Mol. Biol. 53:1995;355-360.
233. Roberts E., Bologa L., Flood J.F., Smith G.E. Effects of dehydroepiandrosterone and its sulfate on brain tissue in culture and on memory in mice. Brain Res. 406:1987;357-362.
234. E. Roberts, L.J. Fitten, Serum steroid levels in two old men with Alzheimer's disease before and after oral administration of dehydroepiandrosterone (DHEA). Pregnenolone synthesis may be rate limiting in aging, in: M. Kalimini, W. Regelson (Eds.), The Biologic Role of Dehydroepiandrosterone (DHEA), Walter de Gruyert, Berlin, 1990, pp. 43-64.
235. Rockstroh S., Emre M., Tarral A., Pokorny R. Effects of the novel NMDA-receptor antagonist SDZ EAA 494 on memory and attention in humans. Psychopharmacology (Berlin). 124:1996;261-266.
236. Roozendaal B., McGaugh J.L. The memory-modulatory effects of glucocorticoids depend on an intact stria terminalis. Brain Res. 709:1996;243-250.
237. Rubinow D.R., Post R.M., Savard R., Gold P.W. Cortisol hypersecretion and cognitive impairment in depression. Arch. Gen. Psychiatry. 41:1984;279-283.
238. Rudman D., Shetty K.R., Mattson D.E. Plasma dehydroepiandrosterone sulfate in nursing home men. J. Am. Geriatr. Soc. 38:1990;421-427.
239. Rupprecht R., Lesch K.P. Psychoneuroendocrine research in depression: I. Hormone levels of different neuroendocrine axes and the dexamethasone suppression test. J. Neural Transm. 75:1989;167-178.
240. Sanchez C., Arnt J., Costall B., Kelly M.E., Meier E., Naylor R.J., Perregaard J. The selective sigma2-ligand Lu 28-179 has potent anxiolytic-like effects in rodents. J. Pharmacol. Exp. Ther. 283:1997;1323-1332.
241. Sanchez C., Meier E. Behavioral profiles of SSRIs in animal models of depression, anxiety and aggression. Are they all alike? Psychopharmacology. 129:1997;197-205.
242. Sandi C., Loscertales M., Guaza C. Experience-dependent facilitating effect of corticosterone on spatial memory formation in the water maze. Eur. J. Neurosci. 9:1997;637-642.
243. Sandi C., Rose S.P. Training-dependent biphasic effects of corticosterone in memory formation for a passive avoidance task in chicks. Psychopharmacology. 133:1997;152-160.
244. Sandi C., Rose S.P.R. Corticosterone enhances long-term retention in one-day-old chicks trained in a weak passive avoidance learning paradigm. Brain Res. 647:1994;106-112.
245. R.M. Sapolsky, Stress, the Aging Brain and the Mechanisms of Neuron Death, MIT Press, Cambridge, MA, 1992.
246. Sapolsky R.M., Krey L.C., McEwen B.S. Prolonged glucocorticoid exposure reduces hippocampal neuron number: implications for aging. J. Neurosci. 5:1985;1222-1227.
247. Sapolsky R.M., Vogelman J.H., Orentreich N., Altmann J. Senescent decline in serum dehydroepiandrosterone sulfate concentrations in a population of wild baboons. J. Gerontol. 48:1993;B196-B200.
248. Schneider L.S., Hinsey M., Lyness S. Plasma dehydroepiandrosterone sulfate in Alzheimer's disease. Biol. Psychiatry. 31:1992;205-208.
249. Schumacher M. Rapid membrane effects of steroid hormones: an emerging concept in neuroendocrinology. TINS. 13:1990;359-362.
250. Schwartz R.D. The GABAA receptor-gated ion channel: biochemical and pharmacological studies of structure and function. Biochem. Pharmacol. 37:1988;3369-3375.
251. Schwarz S., Pohl P. Steroids and opioid receptors. J. Steroid Biochem. Mol. Biol. 48:1994;391-402.
252. Seeman T.E., Robbins R. Aging and the hypothalamic-pituitary-adrenal response to challenge in humans. Endocr. Rev. 15:1994;233-260.
253. Senda T., Matsuno K., Okamoto K., Kobayashi T., Nakata K., Mita S. Ameliorating effect of SA4503, a novel sigma 1 receptor agonist, on memory impairments induced by cholinergic dysfunction in rats. Eur. J. Pharmacol. 315:1996;1-10.
254. Sharp S., Barker E.V., Coughtrie M.W., Lowenstein P.R., Hume R. Immunochemical characterisation of a dehydroepiandrosterone sulfotransferase in rats and humans. Eur.-J.-Biochem. 211:1993;539-548.
255. Sherwin B.B. Estrogen effects on cognition in menopausal women. Neurology. 48:1997;S21-S26.
256. Sherwin B.B., Tulandi T. 'Add-back' estrogen reverses cognitive deficits induced by a gonadotropin-releasing hormone agonist in women with leiomyomata uteri. J. Clin. Endocrinol. Metab. 81:1996;2545-2549.
257. Shimokata H., Muller D.C., Fleg J.L., Sorkin J., Ziemba A.W., Andres R. Age as independent determinant of glucose tolerance. Diabetes. 40:1991;44-51.
258. Sih R., Morley J.E., Kaiser F.E., Perry H.M.r., Patrick P., Ross C. Testosterone replacement in older hypogonadal men: a 12-month randomized controlled trial. J. Clin. Endocrinol. Metab. 82:1997;1661-1667.
259. Singh V.B., Kalimi M., Phan T.H., Boadle-Biber M.C. Intracranial dehydroepiandrosterone blocks the activation of tryptophan hydroxylase in response to acute sound stress. Mol. Cell. Neurosci. 5:1994;176-181.
260. Sjöberg B., de la Torre B., Hedman M., Falkay G., Diczfalusy E. Circadian variation in systemic hormone levels in healthy men. J. Endocrinol. Invest. 2:1979;131-137.
261. Solerte S.B., Fioravanti M., Schifino N., Cuzzoni G., Fontana I., Vignati G., Govoni S., Ferrari E. Dehydroepiandrosterone sulfate decreases the interleukin-2-mediated overactivity of the natural killer cell compartment in senile dementia of the Alzheimer type. Dementia Geriatr. Cognit. Disord. 10:1999;21-27.
262. Sousa A., Ticku M.K. Interactions of the neurosteroid dehydroepiandrosterone sulfate with the GABA(A) receptor complex reveals that it may act via the picrotoxin site. J. Pharmacol. Exp. Ther. 282:1997;827-833.
263. Späth-Schwalbe E., Dodt C., Dittmann J., Schuttler R., Fehm H.L. Dehydroepiandrosterone sulphate in Alzheimer disease. Lancet. 335:1990;1412.
264. Squire L.R. Memory and the hippocampus: a synthesis from findings with rats, monkeys, and humans. Psychol. Rev. 99:1992;195-231.
265. Starkman M.N., Gebarski S.S., Berent S., Schteingart D.E. Hippocampal formation volume, memory dysfunction, and cortisol levels in patients with Cushing's syndrome. Biol. Psychiatry. 32:1992;756-765.
266. Steffensen S.C. Dehydroepiandrosterone sulfate suppresses hippocampal recurrent inhibition and synchronizes neuronal activity to theta rhythm. Hippocampus. 5:1995;320-328.
267. Sternbach H. Age-associated testosterone decline in men: clinical issues for psychiatry. Am. J. Psychiatry. 155:1998;1310-1318.
268. Su T.P. Delineating biochemical and functional properties of sigma receptors: emerging concepts. Crit. Rev. Neurobiol. 7:1993;187-203.
269. Su T.P., Shukla K., Gund T. Steroid binding at sigma receptors: CNS and immunological implications. Ciba Found. Symp. 153:1990;107-113.
270. Sunderland T., Merril C.R., Harrington M.G., Lawlor B.A., Molchan S.E., Matinez R., Murphy D.L. Reduced plasma dehydroepiandrosterone concentrations in Alzheimer's disease. Lancet. ii:1989;570.
271. Svec F., Abadie J., Browne E.S., Porter J.R. Dehydroepiandrosterone and macronutrient selection by obese Zucker rats (fa/fa). Appetite. 25:1995;143-154.
272. Svec F., Hilton C.W., Wright B., Browne E., Porter J.R. The effect of DHEA given chronically to Zucker rats. Proc. Soc. Exp. Biol. Med. 209:1995;92-97.
273. Svec F., Porter J. The effect of dehydroepiandrosterone (DHEA) on Zucker rat food selection and hypothalamic neurotransmitters. Psychoneuroendocrinology. 22:1997;S57-S62.
274. Svec F., Porter J. Effect of DHEA on macronutrient selection by Zucker rats. Physiol. Behav. 59:1996;721-727.
275. Takebayashi M., Kagaya A., Uchitomi Y., Kugaya A., Muraoka M., Yokota N., Horiguchi J., Yamawaki S. Plasma dehydroepiandrosterone sulfate in unipolar major depression. J. Neural Transm. 105:1998;537-542. Short communication.
276. Tollefson G.D., Haus E., Garvey M.J., Evans M., Tuason V.B. Twenty-four-hour urinary dehydroepiandrosterone sulfate in unipolar depression treated with cognitive and/or pharmacotherapy. Ann. Clin. Psychiatry. 2:1990;39-45.
277. Urani A., Privat A., Maurice T. The modulation by neurosteroids of the scopolamine-induced learning impairment in mice involves an interaction with sigma1 (sigma1) receptors. Brain Res. 799:1998;64-77.
278. Van Cauter E., Leproult R., Kupfer D.J. Effects of gender and age on the levels and circadian rhythmicity of plasma cortisol. J. Clin. Endocrinol. Metab. 81:1996;2468-2473.
279. van Weerden W.M., Bierings H.G., van Steenbrugge G.J., de Jong F.H., Schroder F.H. Adrenal glands of mouse and rat do not synthesize androgens. Life Sci. 50:1992;857-861.
280. Vermeulen A., Deslypere J.P., Schelfhout W., Verdonck L., Rubens R. Adrenocortical function in old age: response to acute adrenocorticotropin stimulation. J. Clin. Endocrinol. Metab. 54:1982;187-191.
281. Vollmann-Honsdorf G.K., Flügge G., Fuchs E. Chronic psychosocial stress does not affect the number of pyramidal neurons in tree shrew hippocampus. Neurosci. Let. 233:1997;121-124.
282. Wade C.E., Lindberg J.S., Cockrell J.L., Lamiell J.M., Hunt M.M., Ducey J., Jurney T.H. Upon-admission adrenal steroidogenesis is adapted to the degree of illness in intensive care unit patients. J. Clin. Endocrinol. Metab. 67:1988;223-227. issn:0021-972x.
283. Walker J.M., Bowen W.D., Walker F.O., Matsumoto R.R., De Costa B., Rice K.C. Sigma receptors: biology and function. Pharmacol. Rev. 42:1990;355-402.
284. Weiss B.L. Failure of nalmefene and estrogen to improve memory in Alzheimer's disease. Am. J. Psychiatry. 144:1987;386-387.
285. Wichmann U., Wichmann G., Krause W. Serum levels of testosterone precursors, testosterone and estradiol in 10 animal species. Exp. Clin. Endocrinol. 83:1984;283-290.
286. Winterer J., Gwirtsman H.E., George D.T., Kaye W.H., Loriaux D.L., Cutler G.B. Jr. Adrenocorticotropin-stimulated adrenal androgen secretion in anorexia nervosa: impaired secretion at low weight with normalization after long-term weight recovery. J. Clin. Endocrinol. Metab. 61:1985;693-697.
287. Wolf O.T., Köster B., Kirschbaum C., Pietrowsky R., Kern W., Hellhammer D.H., Born J., Fehm H.L. A single administration of dehydroepiandrosterone does not enhance memory performance in young healthy adults, but immediately reduces cortisol levels. Biol. Psychiatry. 42:1997;845-848.
288. Wolf O.T., Kudielka B.M., Hellhammer D.H., Törber S., McEwen B., Kirschbaum S.C. Two weeks of transdermal estradiol treatment in postmenopausal women and its effect on memory and mood: verbal memory changes are associated with the treatment induced estradiol levels. Psychoneuroendocrinology. 24:1999;727-741.
289. Wolf O.T., Kudielka B.M., Hellhammer J., Hellhammer D.H., Kirschbaum C. Opposing effects of DHEA replacement in elderly subjects on declarative memory and attention after exposure to a laboratory stressor. Psychoneuroendocrinology. 23:1998;617-629.
290. Wolf O.T., Naumann E., Hellhammer D.H., Kirschbaum C. Effects of dehydroepiandrosterone (DHEA) replacement in elderly men on event related potentials (ERPs), memory and well-being. J. Gerontol. 53:1998;M385-M390.
291. Wolf O.T., Neumann O., Hellhammer D.H., Geiben A.C., Strasburger C.J., Dressendörfer R.A., Pirke K.M., Kirschbaum C. Effects of a two-week physiological dehydroepiandrosterone substitution on cognitive performance and well-being in healthy elderly women and men. J. Clin. Endocrinol. Metab. 82:1997;2363-2367.
292. O.T. Wolf, R. Preut, D.H. Hellhammer, B.M. Kudielka, T.H. Schürmeyer, C. Kirschbaum, Testosterone and cognition in elderly men: a single testosterone injection impairs verbal fluency, but has no effects on spatial or verbal memory. Biol. Psychiatry, in press.
293. Wolkowitz O.M., Reus V.I., Keebler A., Nelson N., Friedland M., Brizendine L., Roberts E. Double-blind treatment of major depression with dehydroepiandrosterone (DHEA). Am. J. Psychiatry. 156:1999;646-649.
294. Wolkowitz O.M., Reus V.I., Manfredi F., Ingbar J., Brizendine L. Antiglucocorticoid strategies in hypercortisolemic states. Psychopharmacol. Bull. 28:1992;247-251.
295. Wolkowitz O.M., Reus V.I., Manfredi F., Roberts E. Antiglucocorticoid effects of DHEA-S in Alzheimer's disease. Am. J. Psychiatry. 149:1992;1126.
296. Wolkowitz O.M., Reus V.I., Roberts E. Role of DHEA and DHEA-S in Alzheimer's disease. Am. J. Psychiatry. 150:1993;1433.
297. Wolkowitz O.M., Reus V.I., Roberts E., Manfredi F., Chan T., Raum W.J., Ormiston S., Johnson R., Canick J., Brizendine L., Weingartner H. Dehydroepiandrosterone (DHEA) treatment of depression. Biol. Psychiatry. 41:1997;311-318.
298. Wolkowitz O.M., Reus V.I., Weingartner H., Thompson K., Breier A., Doran A., Rubinow D., Pickar D. Cognitive effects of corticosteroids. Am. J. Psychiatry. 147:1990;1297-1303.
299. Woolley C.S., Gould E., McEwen B.S. Exposure to excess glucocorticoids alters dendritic morphology of adult hippocampal pyramidal neurons. Brain Res. 531:1990;225-231.
300. Wright B.E., Svec F., Porter J.R. Central effects of dehydroepiandrosterone in Zucker rats. Int. J. Obes. Related Metab. Disord. 19:1995;887-892.
301. Xu X., Sonntag W.E. Growth hormone and aging: regulation. signal transduction and replacement therapy. Trends Endocrinol. Metab. 7:1996;145-150.
302. Yaffe K., Ettinger B., Pressman A., Seeley D., Whooley M., Schaefer C., Cummings S. Neuropsychiatric function and dehydroepiandrosterone sulfate in elderly women: a prospective study. Biol. Psychiatry. 43:1998;694-700.
303. Yanase T., Fukahori M., Taniguchi S., Nishi Y., Sakai Y., Takayanagi R., Haji M., Nawata H. Serum dehydroepiandrosterone (DHEA) and DHEA-sulfate (DHEA-S) in Alzheimer's disease and in cerebrovascular dementia. Endocr. J. 43:1996;119-123.
304. Yoo A., Harris J., Dubrovsky B. Dose-response study of dehydroepiandrosterone sulfate on dentate gyrus long-term potentiation. Exp. Neurol. 137:1996;151-156.
305. Young J., Corpechot C., Haug M., Gobaille S., Baulieu E.E., Robel P. Suppressive effects of dehydroepiandrosterone and 3 beta-methyl-androst-5-en-17-one on attack towards lactating female intruders by castrated male mice: II. Brain neurosteroids. Biochem. Biophys. Res. Commun. 174:1991;892-897.
306. Young J., Couzinet B., Pholsena M., Nahoul K., Labrie F., Schaison G. Plasma 3 beta-hydroxy-delta 5-steroids in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J. Clin. Endocrinol. Metab. 78:1994;299-304.
307. Zumoff B., Rosenfeld R.S., Strain G.W., Levin J., Fukushima D.K. Sex differences in the twenty-four hour mean plasma concentrations of dehydroisoandrosterone (DHA) and dehydroisoandrosterone sulfate (DHAS) and the DHA to DHAS ratio in normal adults. J. Clin. Endocrinol. Metab. 51:1980;330-333.
308. Zweifel J.E., O'Brien W.H. A meta-analysis of the effect of hormone replacement therapy upon depressed mood. Psychoneuroendocrinology. 22:1997;189-212.